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Abstract
Cervical lymph node evaluation by clinical ultrasound is a non-invasive procedure used in diagnosing nodal status, and
when combined with fine-needle aspiration cytology (FNAC), provides an effective method to assess nodal pathologies.
Development of high-frequency ultrasound (HF US) allows real-time monitoring of lymph node alterations in animal
models. While HF US is frequently used in animal models of tumor biology, use of HF US for studying cervical lymph nodes
alterations associated with murine models of head and neck cancer, or any other model of lymphadenopathy, is lacking.
Here we utilize HF US to monitor cervical lymph nodes changes in mice following exposure to the oral cancer-inducing
carcinogen 4-nitroquinoline-1-oxide (4-NQO) and in mice with systemic autoimmunity. 4-NQO induces tumors within the
mouse oral cavity as early as 19 wks that recapitulate HNSCC. Monitoring of cervical (mandibular) lymph nodes by gray scale
and power Doppler sonography revealed changes in lymph node size eight weeks after 4-NQO treatment, prior to tumor
formation. 4-NQO causes changes in cervical node blood flow resulting from oral tumor progression. Histological evaluation
indicated that the early 4-NQO induced changes in lymph node volume were due to specific hyperproliferation of T-cell
enriched zones in the paracortex. We also show that HF US can be used to perform image-guided fine needle aspirate (FNA)
biopsies on mice with enlarged mandibular lymph nodes due to genetic mutation of Fas ligand (Fasl). Collectively these
studies indicate that HF US is an effective technique for the non-invasive study of cervical lymph node alterations in live
mouse models of oral cancer and other mouse models containing cervical lymphadenopathy.
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Introduction
The most common route of dissemination for head and neck
cancers is via the local lymphatic system, where patient prognosis
relies heavily on the ability to detect cervical lymph node
involvement [1–3]. Several different imaging modalities are
currently used to enhance pretreatment staging of patients with
head and neck squamous cell carcinoma (HNSCC), including
computed tomography (CT), positron emission tomography
(PET)-CT, magnetic resonance imaging (MRI) and ultrasonogra-
phy [4–7]. Of these, ultrasound has greater clinic availability and
is easiest to employ [6]. When combined with FNAC, ultrasound
provides a highly accurate, sensitive and selective means to assess
lymph node alterations in patients, including tumor cell metastasis
[4,6,8].
The development of high-frequency ultrasound (HF US)
technology has allowed sonography to be performed on rodent
and other small animal disease models. HF US is a noninvasive,
real-time technique that allows imaging of internal structures
down to 30 microns using gray scale or brightness (B)-mode [9].
This resolution allows for real-time monitoring of tumor formation
and progression in vivo in a variety of animal model systems. 3D
reconstructions of HF US 2D images allows for the calculation of
highly accurate tumor and lymph node volumes. In addition,
power Doppler sonography is commonly used to assess and
quantify blood flow velocities in tumors and lymph nodes. The
combination of these two modalities is useful in quantifying tumor-
induced alterations of circulatory flow [10–13].
Several mouse models of HNSCC have been generated that
recapitulate important aspects of the human disease. These
include orthotopic xenografts, genetically engineered mouse
models and carcinogen-initiated tumors [14,15]. Common
carcinogens used to spontaneously generate rodent HNSCC
include 7,12-dimethylbenz(a)anthracene or 9,10-dimethyl-1,2-
benzanthracene (DMBA) and 4-nitroquinoline-1-oxide (4-NQO)
[16]. The 4-NQO oral cancer model is a prevalent method to
induce HNSCC in mice, as it closely mimics the oncogenic effect
of tobacco carcinogens and copies many key molecular alterations
that occur during human HNSCC development [17,18], including
lymph node metastasis [19]. Tumor induction is achieved by the
addition of 4-NQO to the drinking water of immunocompetent
mice, with tumor development followed over a period of several
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weeks to months. The degree and swiftness of carcinogenesis is
dependent on the exposure time and 4-NQO dosage [20–22].
While many studies have investigated the effects of 4-NQO on
multiple aspects of rodent oral cancer [20,21,23–28], reports
examining the impact of 4-NQO exposure on murine lymph node
biology are lacking [19].
While diagnostic ultrasound affords practical utility in evaluat-
ing pre- and cancerous changes within patient cervical lymph
nodes, adapting HF US to evaluate cervical nodal alterations in
mouse HNSCC or other model systems has not been reported.
Here we show that HF US can be utilized for monitoring changes
in cervical lymph nodes in 4-NQO-treated mice during the course
of oral cancer progression. C57BL/6 (B6) mice treated with 4-
NQO for eight weeks displayed increased lymph node volume and
vascular flow prior to oral tumor development. Histological
evaluation determined that pre-cancerous elevation of lymph node
volume was specifically due to increased proliferation of intranodal
T-cell zones. Furthermore, we show that HF US can be utilized to
obtain image-guided FNA biopsy material from Fasl mice that
contain chronically enlarged cervical nodes. The ability of HF US
to conduct real time monitoring of murine cervical lymph node
dynamics allows for the practical detection of neck node changes
in mice that cannot be accomplished by conventional histology.
This technique ultimately provides increased utility and accuracy
for studies involving live rodent models of HNSCC and other
rodent systems that model cervical node lymphadenopathy.
Materials and Methods
Mice
B6 and CPt.C3-Faslgld/J (Fasl) mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). FVB mice were a generous
gift from John Hollander (West Virginia University). All animal
studies were approved by the WVU Institutional Animal Care and
Use Committee (protocol 11-0412) and conducted in accordance
with the principles and procedures outlined in the NIH Guide for
the Care and Use of Animals.
4-NQO administration
22–24 week old B6 mice were given 50–100 mg/mL 4-NQO
(Sigma, St Louis, MO) in their drinking water ad libitum for eight
weeks, with water changed at weekly intervals. Normal drinking
water was resumed at the end of the eight-week treatment.
High-frequency ultrasonography and image analysis
Ultrasound imaging was performed using a VisualSonics Vevo
2100 micro-ultrasound system (Toronto, Ontario, Canada) on
control (n = 4) and 4-NQO-treated (n = 3) mice. Mice were
initially anesthetized with 3% isoflurane with oxygen and
maintained at 1–2% isoflurane with oxygen during imaging.
Anesthetized mice were positioned in dorsal recumbancy on a
heated imaging platform and paws taped to electrocardiograph
(ECG) leads to monitor heart and respiration rates. Body
temperature was maintained at 37uC and monitored with a rectal
probe thermometer. Hair was removed from the neck region using
a chemical depilatory (Nair, Church & Dwight, NJ). A 40 MHz
transducer was used for lower resolution overview imaging of the
neck region from the thyroid gland through to the posterior
tongue. All other images were acquired using a 50 MHz
transducer. Images were taken in 3D-mode using combined B-
and power Doppler mode. Lymph node volume and percent blood
flow were determined using Vevo 2100 software after drawing
regions of interest within each sequential 2D image. On average,
each mouse took approximately 15 minutes to prepare and image.
Image-guided fine needle biopsy
Enlarged mandibular cervical nodes in anesthetized Fasl mice
were identified using the 50 MHz transducer focused at the lymph
node center. A 27 K gauge needle attached to a 1 ml syringe was
inserted into the micro-injector, consisting of an adjustable needle
holder with micro-manipulation controls. The needle was
positioned bevel side up and inserted through the skin into the
mandibular node. After ,100 ml of lymph tissue was extracted,
the needle was removed and the syringe placed in a 2 mL
microcentrifuge tube. The syringe was filled with 1 mL of
ThinPrep media and reattached to the needle. The media was
dispensed for rinsing and processed by Cytospin using a blue filter
in a Thinprep 2000 processor (Cytyc, Marlborough, MA).
Immunohistochemical analysis
Whole necks, cervical lymph nodes and tongues were dissected,
rinsed in PBS, fixed in 10% neutral buffered formalin (Fisher,
Pittsburgh, PA) and embedded in paraffin. Whole neck sections
required decalcification using Rapid-CalNImmuno decalcification
solution (BBC Biochemical, Seattle, WA) after fixation. Five-
micrometer sections from tissue blocks were stained with
hematoxylin and eosin (H&E) or immunolabeled with prediluted
cytokeratin 14 antibody (Abcam, Cambridge, MA) using a
Discovery XT automated staining system (Ventana Medical
Systems, Tucson, AZ). Lymph node paracortical T-cell zone
expansion analysis was performed by pathological evaluation on
H&E stained sections after grouping nodes by right or left side.
Individual nodes were scored as having none, moderate or robust
enlargement. Histological images were obtained using an Olympus
AX70 Provis microscope (Center Valley, PA).
Statistical analysis
Differences between groups were evaluated using Student’s t-
test with significance determined at p#0.05.
Results
High-frequency ultrasound detection of mouse cervical
lymph nodes
Cervical ultrasound is a commonly utilized tool for non-invasive
imaging of lymph nodes in the patient neck, where it is frequently
combined with MRI and PET/CT to determine patient staging in
HNSCC and other diseases. While several publications describe
the features of benign and malignant cervical lymph nodes in
humans [29–33], studies detailing the suitability and use of US to
image normal or diseased mouse cervical nodes are lacking. We
initially conducted HF US on untreated B6 mice to identify and
map the three supraclavicular (mandibular, accessory mandibular
and superficial parotid [34]) cervical lymph nodes in the murine
neck that drain the oral cavity tissues. Anesthetized mice were
imaged on a heated platform with the Vevo 3D-mode scanner in
order to automate the process (Figure 1A). For point of reference,
the transducer was first focused on the thyroid gland, where it is
well-defined as a hyperechoic solid structure when imaged by gray
scale sonography (Figure 1B and C) [35–38]. Subsequent serial HF
US images were taken of the entire neck region, starting at the jaw
base and moving proximally to the thyroid (diagramed in
Figure 1B). Corresponding HF US images identified each cervical
node as hypoechoic oval structures within dense hyperechoic
regions (Figure 1C). These hyperechoic areas primarily contain
adipose, salivary gland and skeletal muscle tissue adjacent to the
cervical lymph nodes, with the nodes positioned just below the
integument when identified by histological analysis of parallel
tissue sections (Figure 1D). The superficial nature of the cervical
Ultrasound Imaging of Mouse Cervical Lymph Nodes
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nodes increased their mobility due to the pressure placed by the
transducer on the neck, resulting in equivalent right and left nodes
appearing in different imaging planes. This was countered by
making compensatory adjustments to the imaging stand while
maintaining the transducer in a stationary position. Insertion of a
metal feeder needle into the oral cavity during imaging ablated the
ultrasound signal, allowing additional imaging of buccal regions
and esophagus to provide a more comprehensive sonographic
depiction of the murine oral cavity (Figure S1).
Since FNAC of lymph nodes is used to determine patient tumor
staging and for other diagnostic purposes, we determined the
feasibility of conducting HF US image-guided FNAC analysis on
live mice. The cervical nodes in B6 mice proved too small and
mobile obtain a FNA. We therefore used Fasl mice that contain
enlarged lymph nodes due to systemic autoimmunity [39,40] that
mimic the size of human lymph nodes (Figure 2A). FNAC of Fasl
cervical mandibular nodes was performed using an image-guided
microinjection system with the 50 MHz transducer focused at the
presumed lymph node center (Figure 2B; Video S1). The entire
biopsy can be seen in Video S1. Analysis of the aspirated material
following Cytospin concentration exclusively revealed cellular and
extracellular lymph node components, including large clumps of
lymph tissue, individual lymphocytes and reticular fibers
(Figure 2C). These results indicate that HF US can be successfully
adapted for FNA analysis on enlarged cervical lymph nodes in
mice.
4-NQO induces pre-cancerous enlargement of mouse
submandibular lymph nodes
We next used HF US to monitor cervical lymph node changes
in mice following oral 4-NQO exposure designed to induce
tumorigenesis. B6 mice were selected since this strain exhibits near
complete penetrance and predictable oral tumor course in
response to 4-NQO treatment [28,29]. Mice were given 4-NQO
continuously for eight weeks as previously reported [20–22]. For
clarity, the end of the eight week treatment period is denoted as
the zero week time point in the study. Mice formed oral lesions
similar to those reported in previous studies, starting as early as 19
weeks post-treatment [20,22] (Figure S2A). The neck region in
control and 4-NQO treated mice was imaged every four weeks by
HF US for an additional 28 weeks after the zero week time point.
B-mode imaging of the mandibular and accessory mandibular
lymph nodes in 4-NQO treated mice at the end of the entire 36
week study period indicated slight increases in lymph node size
Figure 1. Mapping of mouse cervical lymph nodes by high frequency ultrasound. A. Overview image of the HF US platform for cervical
lymph node evaluation. An anesthetized B6 mouse is shown positioned on the Vevo 2100 heated imaging platform with the ventral side exposed.
Each paw is tapped to a monitoring electrode and the rectal probe (blue) secured to the stage. The transducer (white) is positioned over the ventral
neck area. B. Diagram showing relative locations of murine cervical lymph nodes. Individual neck sections visualized by HF US imaging and histology
are indicated by dashed lines. Arrows denote specific positions of each mapped section relative to corresponding ultrasound and histology images.
Each imaged anatomical location is numbered. M, mandibular node. AM, accessory mandibular node. SP, superficial parotid node. C. Serial transverse
sections of the mouse neck imaged by HF US corresponding to the indicated anatomic regions in (B). D. Transverse cervical H&E stained histological
sections corresponding to the HF US sections in (C). Arrows labeled ‘‘2’’ denote mandibular node as diagrammed in B. Scale bar = 1 mm. CP, cheek
pouch. VT, ventral tongue. DT, dorsal tongue. E, esophagus.
doi:10.1371/journal.pone.0100185.g001
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compared to nodes from age-matched control animals (Figure 3A
and B, Videos S2-S3). In a separate study, 4-NQO-treated B6
mice developed lymph node metastasis by 33 weeks post-4-NQO
treatment (41 weeks total), demonstrating that 4-NQO-induced
tumors are capable of undergoing lymph node metastasis during
the later stages of oral cancer progression (Figure S2B).
The increased mandibular node size in 4-NQO treated mice at
the end of 36 weeks was comparable to the mandibular node size
in Fasl mice in many instances (Figure 3C, Video S4). Three
dimensional volume measurements revealed median mandibular
nodal volumes of 3.1 mm3 in control mice and 4.4 mm3 in 4-
NQO treated mice 28 weeks after cessation of 4-NQO treatment
(Figure 3D). Interestingly, mandibular node volume measured by
HF US at the end of the initial eight-week 4-NQO treatment
period (prior to tumor onset) was significantly greater than nodes
in control mice (Figure 3D; 1.3 mm3 vs 4.9 mm3, respectively).
This finding was surprising since there was no evidence of tumor
onset in 4-NQO treated mice at this time, suggesting an early
inflammatory response in these nodes, potentially due to
hyperkeratosis present on the tongues of these animals (Figure
S2A, 0 weeks post-4-NQO). Power Doppler analysis of the
mandibular nodes indicated that while intranodal median vascular
flow rates were comparable within nodes in age-matched control
and 4-NQO treated mice immediately following 4-NQO treat-
ment, median vascular flow in 4-NQO exposed nodes was
increased by close to 15% in mice 28 weeks after the end of 4-
NQO exposure (Figure 3E). Although median blood flow
percentages were largely different between age-matched control
and 4-NQO treated mice at 28 weeks (7.4% vs 17.83%, Figure 3E),
the overall change did not reach statistical significance. Blood flow
between age-matched non-treated controls at 0 and 28 weeks also
did not increase significantly. The increased nodal blood flow in
28 wk animals was not due to the increase in lymph node volume
in these mice, since the amount of vascular flow in Fasl
mandibular nodes was comparable to the flow percentages in
control and 4-NQO treated mice at the zero week time point
(Figure 3E). Collectively these results suggest that 4-NQO
treatment in B6 mice results in precancerous mandibular lymph
node enlargement accompanied by increased intranodal blood
flow during tumor onset and progression.
Acute 4-NQO exposure in B6 mice enhances expansion
of the mandibular lymph node paracortical/T-cell zone
Mandibular lymph nodes from 4-NQO exposed mice 28 weeks
post-treatment displayed areas of increased lymphocyte density
compared to age-matched controls (Figure 3B versus Figure 3A),
suggesting that lymphocyte proliferation could be responsible for
the increased submandibular nodal volume observed by HF US.
Pathological evaluation of H&E-stained sections containing all
cervical lymph nodes from both sides of the neck revealed varying
degrees of enlargement of the T-cell enriched paracortical zones in
control and 4-NQO exposed mice (Figure 4A and 4B). However,
lymph nodes in 4-NQO exposed mice had a greater degree of
paracortical T-cell enlargement, with over 80% of the nodes
scored as containing robust expansion of this region (Figure 4C).
In contrast, none of the paracortical regions in control nodes
displayed more than moderate T-cell expansion (Figure 4C).
These results suggest that 4-NQO exposure induces increased
cervical lymph node volume attributable to specific hyperproli-
feration of the nodal T-cell population.
Discussion
Clinical sonography has emerged as an important means of
monitoring cervical lymph node changes in HNSCC and other
oral diseases. In this study, we show that cervical lymph nodes in
mouse can be effectively identified and imaged by HF US.
Combined gray scale and power Doppler sonography revealed
increased nodal volume and blood flow in mice treated with 4-
NQO prior to tumor formation. The increase in overall pre-
cancerous cervical node size in 4-NQO exposed mice can be
attributed to expansion of the paracortical/T-cell zone within the
node. We also demonstrate that HF US image-guided biopsies can
be successfully conducted on live mice using a mutant Fasl strain
that displays chronic cervical lymphadenopathy. Collectively these
results support the application and utility of HF US for the
Figure 2. Image-guided fine needle biopsy of Fasl mandibular lymph nodes. A. Transverse section of a Fasl mouse neck imaged with HF
US. The enlarged cervical mandibular node is evident as an oval hypoechoic region near the skin surface (circumscribed in yellow). Scale bar = 1 mm.
B. Frames from fine needle biopsy of a Fasl mandibular node guided by HF US. Images show the position of the sampling hyperechoic needle tip
prior to cervical skin penetration (left), position of the needle during tissue removal (middle), and following needle withdrawal (right). Note the break
in the skin following needle withdrawal (arrow). The angle and trajectory of the dorsal needle surface is denoted by the yellow dotted line. Scale bar
= 1 mm. The entire procedure is shown in Video S1. C. Examples of lymph tissue obtained by HF US guided FNA of a Fasl cervical mandibular node
following staining and processing by cytospin. Scale bar = 100 mm. LT; lymph tissue, RF; reticular fibers, L; individual lymphocytes.
doi:10.1371/journal.pone.0100185.g002
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Figure 3. 4-NQO exposure induces precancerous alterations in mouse mandibular lymph nodes. A–C. Images of dissected H&E and
whole animal HF US (ultrasound) mandibular lymph nodes from representative age-matched (AM) control (A), 4-NQO-treated (28 wk) (B) and Fasl (C)
mice. Lymph node borders in the HF US images are indicated in yellow. Vascular flow identified by power Doppler imaging is shown in red. Power
Doppler flow dynamics for each condition are visualized in Video S2–S4. H&E scale bar = 250 mm, ultrasound scale bar = 1 mm. CP, Cheek Pouch.
D&E. Analysis of lymph nodes by HF US. 4-NQO treated mice at 0 and 28 wk were imaged after 8 week 4-NQO treatment and study end point. B6
age-matched (AM) Ctl 0 and 28 wk mice were imaged at the same age as 4-NQO treated mice. The Fasl lymph node data is included for comparison.
D. 4-NQO exposure induces increased mandibular lymph node volume. E. 4-NQO exposure increases vascular flow in mandibular nodes. N = 6 lymph
nodes from 3 mice per group, except for the controls, where N = 8 lymph nodes were analyzed from 4 mice. Box and whisker plots show minimum,
25th, median, 75th and maximum values, respectively. *, p#0.05.
doi:10.1371/journal.pone.0100185.g003
Figure 4. 4-NQO treatment induces paracortical/T-cell zone hyperplasia in mandibular lymph nodes. Representative examples of H&E
stained, dissected mandibular lymph nodes from age-matched (A) control and (B) 4-NQO-treated (28 wk) mice. T-cell zone expansions in each node
are circumscribed in yellow. Scale bar = 250 mm. C. Distribution of nodal paracortical/T-cell zone hyperplasia. Mandibular lymph nodes were
pathologically scored and grouped according to relative scale of T-cell zone involvement, using the following scale: None, absent to focal limited
expansion; Modest, multifocal or focal up to moderate expansion; Robust, multifocal moderate expansion and/or confluence of paracortical
subregions.
doi:10.1371/journal.pone.0100185.g004
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minimally invasive study of cervical lymph nodes in mouse models
of HNSCC and other diseases.
Examination of the mouse cervical region by HF US provides
an in vivo map of cervical lymph node position that closely
matches node location in histological sections. This mapping is in
agreement with previous studies of the thyroid and tongue that
charted these regions on a more limited level [36,41]. Due to their
inherent small size, an accurate, comprehensive in situ portrayal of
mouse cervical lymph nodes is useful not only to mouse models of
HNSCC, but other systems pertaining to illness causing cervical
lymphadenopathy, including thyroid cancer [37,38] and bacterial
infection [42]. HF US can also be applied to study cervical organs
other than lymph nodes. Salivary gland diseases such as salivary
gland tumors, sialolithiasis, sialodenitis and Sjogren’s syndrome
[43] all have the potential to have organ-induced alterations
visualized by HF US in rodent models.
FNAC is an important technique used to aid in diagnosing
nodal involvement in HNSCC and other diseases. Here we
demonstrate that image-guided FNAC can be successfully utilized
to obtain biopsy material from Fasl mice with systemic lymph-
adenopathy. These mice have lymph node sizes similar to humans
[44,45], with volumes comparable to enlarged cervical nodes due
to 4-NQO exposure and subsequent HNSCC tumor progression
(Figure 3D). This implies that successful biopsies can be performed
on any enlarged mouse lymph with similar volume. HF US-guided
FNAC therefore has the potential to detect lymph node metastases
in HNSCC mouse models, and is planned for future studies where
longer term HF US monitoring of animals from pre-cancerous
stages through tumor development and progression is achieved.
The ability to conduct image-guided FNAC on cervical lymph
nodes imparts translational impact on such mouse model studies,
where tumor staging is typically based on the degree of nodal
metastases [46,47].
Mice orally treated with 4-NQO displayed several different
changes in cervical lymph node biology unrelated to metastatic
involvement that can be overlooked if not for the real-time
capabilities of ultrasonography. 4-NQO-treated mice develop
enlarged lymph nodes that correspond with early alterations to the
tongue epithelium, where enlargement is maintained during tumor
onset and progression. While enlarged nodes can be expected in
response to neoplastic development, growth and/or metastasis,
our findings indicate that significant lymph node enlargement
occurs before tumor formation occurs in the oral cavity. The
increased node size can be explained by paracortical/T-cell zone
hyperplasia within the cervical nodes (Figure 4). Similar findings of
paracorticial T-cell expansion have been observed in patients with
oral cavity or oropharynx tumors [48,49], but the underlying
mechanism for this is unclear. Patient intranodal paracortical
expansion is more pronounced in nodes without tumor infiltration
[48,49], in agreement with our data, as we did not observe
metastasis in any analyzed cervical lymph node in this study
(Figure 4). However, since 4-NQO-treated mice develop cervical
node metastases at time points later than what were monitored in
the present study (Figure S2B), it is conceivable that HF US can be
employed to analyze volume changes in cervical nodes containing
tumor metastases, as noted above.
In addition to increased cervical lymph node volume, power
Doppler HF US demonstrated that 4-NQO treated mice have
greater median blood flow in their mandibular node after tumor
onset (Figure 3E). Primary tumors have been shown to induce
vasculature reorganization within downstream lymph nodes,
preparing the nodal microenvironment (‘‘soil’’) prior to tumor
cell arrival (‘‘seed’’) in order to better support metastatic
colonization [50]. This is achieved by angiogenic induction of
microvasculature, including high endothelial venules, within
lymph nodes before tumor cell arrival [50–52]. However, we did
not observe changes in cervical node microvessel density or size in
4-NQO treated mice (data not shown). The systemic cause for the
4-NQO-mediated increase in cervical nodal blood flow is currently
under investigation.
In summary, we demonstrate the benefits of using HF US
technology to monitor cervical lymph node alterations in a mouse
model of oral cancer. Real-time monitoring of lymph node
biological responses is an important aspect in therapeutic and
biomarker development. Detection of lymph node metastasis
without the need for immediate sacrifice allows for more
comprehensive and long-term study of animal disease models. In
addition to HNSCC, other disease models that induce murine
cervical lymphadenopathy may benefit from the application of HF
US, allowing improved evaluation of cervical nodes in a variety of
experimental prognostic and diagnostic settings.
Supporting Information
Figure S1 Visualization of regions within the mouse
neck by high-frequency ultrasound. HF US imaging of the
mouse oral cavity following placement of an oral gavage needle in
mouth to dampen the US signal, aiding with identification of
different sections during imaging. Arrows point to area probed
with needle, which can be seen in each image blocking ultrasound
signal. Scale bar = 1 mm.
(TIF)
Figure S2 4-NQO exposure induces changes in mouse
tongue epithelium similar to human HNSCC and results
in cervical lymph node metastasis. A. H&E and cytokeratin
14 staining of representative mouse tongues: control untreated,
after 8 weeks of treatment, and after termination at 19 weeks due
to tumor burden as an example to validate the ability of 4-NQO to
induce oral tumors. Scale bar = 100 mm. B. Cytokeratin 14
staining of mouse mandibular node from 4-NQO-treated animal
33 weeks after the end of 4-NQO treatment. Inset demonstrates
cytokeratin 14-positive cells indicating epithelial origin, confirming
tumor metastasis.
(TIF)
Video S1 Image-guided fine needle biopsy of Fasl
mouse lymph node.
(AVI)
Video S2 HF US and Power Doppler of age-matched
control mouse cervical lymph node. Representative video of
3D scan of control mandibular node using combined B-mode and
power Doppler imaging modalities. The red areas within the video
represent blood flow.
(AVI)
Video S3 HF US and Power Doppler of 4-NQO-treated
(28 wk) mouse cervical lymph node. Representative video of
3D scan of 4-NQO-treated mandibular node using combined B-
mode and power Doppler imaging modalities. The red areas
within the video represent blood flow.
(AVI)
Video S4 HF US and Power Doppler of Fasl mouse
cervical lymph node. Representative video of 3D scan of Fasl
mandibular node using combined B-mode and power Doppler
imaging modalities. The red areas within the video represent
blood flow.
(AVI)
Ultrasound Imaging of Mouse Cervical Lymph Nodes
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